Skip to content

The Singapore Tele-technology Aided Rehabilitation in Stroke (STARS) Study

The Singapore Tele-technology Aided Rehabilitation in Stroke (STARS) Study: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01905917
Acronym
STARS
Enrollment
124
Registered
2013-07-23
Start date
2013-11-30
Completion date
2017-09-30
Last updated
2017-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke

Brief summary

The primary hypothesis tested in this randomized control trial is that a tele-rehabilitation intervention involving video-conferencing with a therapist and use of wearable monitoring devices in the first three months after stroke results greater functional recovery using the Jette Late Life Functional and Disability Instrument (LLFDI) (primary outcome) among stroke at three months survivors compared to usual care. The secondary hypotheses tested in this randomized control trial are that a tele-rehabilitation intervention involving video-conferencing with a therapist and use of wearable monitoring devices in the first three months after stroke results in: * Functional recovery using the LLFDI at 6 months, * Functional recovery using gait speed, 2-minute walk test and Shah modified Barthel Index at 3 and 6 months, * Greater contact time with a therapist at 3 & 6 months, * Better balance at 3 & 6 months, * Better self-report health-related quality of life at 3 & 6 months, * Decreased health service utilization at 3 & 6 months, * Reduced caregiver burden at three months survivors compared to usual care at 3 & 6 months.

Interventions

Sponsors

Singapore Millennium Foundation
CollaboratorUNKNOWN
Singapore General Hospital
CollaboratorOTHER
Ang Mo Kio - Thye Hua Kwan Hospital
CollaboratorOTHER
National University of Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 40 years; 2. Recent stroke (defined as stroke symptoms occurring within 4 weeks prior to admission into community hospitals); 3. Diagnosis of stroke made by clinician and/or supported by brain imaging; 4. Able to sit unsupported for 30 seconds; 5. Able to stand on the non-paretic leg for \>4 sec; 6. Able to walk at least 2m with maximum of 1 person assist; 7. Able to follow a 3-step command; 8. Living in the community before discharge and expected to be discharged home; 9. Has a caregiver.

Exclusion criteria

1. Has a pacemaker in-situ (because of possible interference of pacemakers by wireless electronic signals); 2. Unable to ambulate at least 150 feet prior to stroke, or intermittent claudication while walking less than 200 meters; 3. Serious cardiac conditions (hospitalization for myocardial infarction or heart surgery within 3 months, history of severe congestive heart failure, serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living); 4. History of serious chronic obstructive pulmonary disease or oxygen dependence; 5. Severe weight bearing pain; 6. Pre-existing neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS) or severe dementia 7. History of major head trauma with severe residual deficits; 8. Lower extremity amputation; 9. Legal blindness or severe visual impairment; 10. Severe uncontrolled psychiatric illness such as psychosis, schizophrenia or medication refractory depression; 11. Life expectancy less than three months; 12. Severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of \> 10°, knee flexion ROM \< 90°, hip flexion contracture \> 25°, and ankle plantar flexion contracture \> 15°); 13. History of sustained alcoholism or drug abuse in the last six months; 14. Hypertension with systolic blood pressure greater than 200 mmHg and diastolic blood pressure greater than 110 mmHg at rest, that cannot be medically controlled into the resting range of 180/100 mmHg.

Design outcomes

Primary

MeasureTime frameDescription
Jette Late Life Functional and Disability Instrument (LLFDI)3 monthsDisability component of the Jette Late Life Functional and Disability Instrument (LLFDI)

Secondary

MeasureTime frameDescription
Jette Late Life Functional and Disability Instrument (LLFDI)6 monthsDisabiity component of Jette Late Life Functional and Disability Instrument (LLFDI)

Other

MeasureTime frameDescription
Shah-modified Barthel Index3 & 6 monthsShah-modified Barthel Index
Activities-Specific Balance Confidence Scale3 & 6 monthsActivities-Specific Balance Confidence Scale
Gait speed3 & 6 monthsGait speed
Health service utilization (perform cost-effectiveness analyses) using the Singapore Stroke Study Health Service Utilization Form3 & 6 monthsHealth service utilization (perform cost-effectiveness analyses) using the Singapore Stroke Study Health Service Utilization Form
Caregiver reported stress using the Zarit Caregiver Burden Inventory3 & 6 monthsCaregiver reported stress using the Zarit Caregiver Burden Inventory
Self-reported health-related quality-of-life using the Euro-QOL (EQ-5D)3 & 6 monthsSelf-reported health-related quality-of-life using the Euro-QOL (EQ-5D)
Two-Minute Walk test3 & 6 monthsTwo-Minute Walk test

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026